HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.

Abstract
IgG subclasses against lipoarabinomannan of mycobacteria were analyzed in the sera of leprosy patients. Patients with active leprosy [tuberculoid and lepromatous, patients undergoing erythema nodosum leprosum (ENL) and reversal reactions] and inactive cases (tuberculoid and lepromatous who were cured after chemotherapy) were included in this study. Active lepromatous patients had higher levels of IgG subclasses, except IgG4, compared to active tuberculoid patients. Some of the inactive cases (lepromatous patients cured after chemotherapy) were positive for the IgG1, IgG2 and IgG3 subclasses. However, their levels are lower than active lepromatous cases. On the other hand, no difference in the subclass levels between the active and inactive tuberculoid groups could be observed. While a significant fall in the level of IgG3 in ENL was observed as compared to lepromatous leprosy without ENL, higher levels of IgG1 and IgG2 were found in patients with reversal reactions compared to their active counterparts without reactions.
AuthorsM K Beuria, K K Mohanty, K Katoch, U Sengupta
JournalInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (Int J Lepr Other Mycobact Dis) Vol. 67 Issue 4 Pg. 422-8 (Dec 1999) ISSN: 0148-916X [Print] United States
PMID10700917 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Immunoglobulin G
  • Lipopolysaccharides
  • lipoarabinomannan
Topics
  • Antibodies, Bacterial (classification)
  • Antigens, Bacterial (immunology)
  • Humans
  • Immunoglobulin G (classification)
  • Leprosy (blood, drug therapy)
  • Leprosy, Borderline (blood, drug therapy)
  • Leprosy, Lepromatous (blood, drug therapy)
  • Leprosy, Tuberculoid (blood, drug therapy)
  • Lipopolysaccharides (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: